XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.2

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Schedule of Diluted Net Income (Loss) Per Share

The following tables reconcile the components of the numerator and denominator included in the calculation of diluted net income (loss) per share:

						Three Months Ended September 30,
						2020						2019
Numerator
Net income (loss) attributed to Inovio Pharmaceuticals, Inc. (numerator for use in basic net income (loss) per share)						$	19,171,336					$	(23,090,693)
Adjustment for decrease in fair value of derivative liability and interest expense						—						(2,177,250)
Numerator for use in diluted income (loss) per share						$	19,171,336					$	(25,267,943)
Denominator
Weighted average number of common shares outstanding (denominator for use in basic net income (loss) per share)						165,355,540						99,007,985
Effect of dilutive potential common shares						9,020,862						3,799,071
Denominator for use in diluted net income (loss) per share						174,376,402						102,807,056
Net income (loss) per share, diluted						$	0.11					$	(0.25)
Net income (loss) per share, basic						$	0.12					$	(0.23)

						Nine Months Ended September 30,
						2020						2019
Numerator
Net loss attributed to Inovio Pharmaceuticals, Inc. (numerator for use in basic net loss per share)						$	(142,072,777)					$	(81,697,181)
Adjustment for decrease in fair value of derivative liability and interest expense						—						—
Numerator for use in diluted loss per share						$	(142,072,777)					$	(81,697,181)
Denominator
Weighted average number of common shares outstanding (denominator for use in basic net loss per share)						148,656,454						98,204,375
Effect of dilutive potential common shares						—						—
Denominator for use in diluted net loss per share						148,656,454						98,204,375
Net loss per share, diluted						$	(0.96)					$	(0.83)
Net loss per share, basic						$	(0.96)					$	(0.83)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes potential shares of common stock that were excluded from the diluted net income (loss) per share calculation because of their anti-dilutive effect for the three months ended September 30, 2020 and 2019:

Common Stock Equivalents			2020						2019
Options to purchase common stock			119,438						9,971,297
Service-based restricted stock units			—						2,121,359
Convertible preferred stock			3,309						8,456
Convertible notes			11,039,574						14,585,653
August 2019 Bonds			—						—
December 2019 Bonds			1,009,450						—
Total			12,171,771						26,686,765

The following table summarizes potential shares of common stock that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect for the nine months ended September 30, 2020 and 2019:

Common Stock Equivalents			2020						2019
Options to purchase common stock			9,290,347						9,971,297
Service-based restricted stock units			2,586,915						2,121,359
Performance-based restricted stock units			663,353						—
Convertible preferred stock			3,309						8,456
Convertible notes			11,039,574						14,585,653
August 2019 Bonds			—						3,799,071
December 2019 Bonds			1,009,450						—
Total			24,592,948						30,485,836

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration